Monika Horvathova Selected Research

Polycythemia (Erythrocytosis)

1/2023	Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis.
1/2023	Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen-sensing pathway from primary familial and congenital polycythaemia.
10/2022	Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
1/2016	Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monika Horvathova Research Topics

Disease

4	Polycythemia (Erythrocytosis) 01/2023 - 01/2016
4	Iron Deficiencies 10/2022 - 04/2010
4	Iron Overload 11/2018 - 04/2010
3	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 11/2022 - 07/2014
2	Hypoxia (Hypoxemia) 01/2023 - 08/2015
2	primary familial and congenital Polycythemia 01/2023 - 01/2016
2	Inflammation (Inflammations) 01/2023 - 12/2018
2	Anemia 11/2022 - 11/2018
2	Thalassemia 11/2018 - 06/2016
2	Hypersensitivity (Allergy) 01/2016 - 03/2008
2	hypochromic microcytic Anemia 01/2014 - 10/2012
1	Obstructive Sleep Apnea 01/2023
1	Hemochromatosis (Bronze Diabetes) 01/2023
1	Reticulocytosis 01/2023
1	Acute Erythroblastic Leukemia (Erythroleukemia) 12/2020
1	Ulcerative Colitis 12/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2018
1	Crohn Disease (Crohn's Disease) 12/2018
1	beta-Thalassemia (Cooley's Anemia) 11/2018
1	Hemolytic Anemia 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Iron Metabolism Disorders 06/2016
1	Pyruvate Kinase Deficiency of Red Cells 05/2014
1	Hemolysis 05/2014
1	Neoplasms (Cancer) 01/2014
1	Polycythemia Vera 01/2014
1	Shock 01/2014
1	X-linked sideroblastic anemia 01/2011
1	Essential Thrombocythemia 03/2008

Drug/Important Bio-Agent (IBA)

9	IronIBA 01/2023 - 04/2010
8	HepcidinsIBA 01/2023 - 05/2014
6	Erythropoietin FDA Link 01/2023 - 03/2008
3	Ferritins (Ferritin)IBA 01/2018 - 05/2014
2	CatalaseIBA 01/2023 - 08/2015
2	Ribosomal Proteins (Ribosomal Protein)IBA 11/2022 - 01/2020
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2018 - 06/2016
2	MetalsIBA 01/2014 - 10/2012
1	AntioxidantsIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Ion Channels (Ion Channel)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Janus Kinase 2IBA 01/2023
1	Adenosine DeaminaseIBA 11/2022
1	CytokinesIBA 12/2020
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 11/2018
1	GlobinsIBA 11/2018
1	Heme (Haem)IBA 11/2018
1	tin protoporphyrin IXIBA 11/2018
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 01/2018
1	Growth Differentiation Factor 15IBA 06/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016
1	PhosphatidylserinesIBA 01/2016
1	Pyruvate KinaseIBA 05/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	Core Binding Factor Alpha 2 SubunitIBA 01/2014
1	Annexin A5IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	5-Aminolevulinate SynthetaseIBA 01/2011
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2011

Therapy/Procedure

2	Therapeutics 01/2023 - 11/2018
1	Blood Transfusion (Blood Transfusions) 05/2014